Loading... Please wait...

Arrowhead Pharmaceuticals, Inc. (ARWR) Analyst Forecast

Currency in USD Disclaimer
$25.07 -$0.15 (-0.59%)
$24.85
$26
$20.67
$39.83
  • Consensus Rating

    Hold

    Based on 4 Analyst Ratings

  • Consensus Price Target

    $52.29

    108.58% Upside

Recent Analyst Forecasts and Stock Ratings


Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
06/04/2024 Goldman Sachs Andrea Tan $31.00 $25.29   22.58%
05/30/2024 RBC Capital Luca Issi $50.00 $22.87   118.63%
01/18/2022 Goldman Sachs Madhu Kumar $85.00 $53.79   58.02%

Arrowhead Pharmaceuticals, Inc. Frequently Asked Questions

  • Q. What analysts cover Arrowhead Pharmaceuticals, Inc.?

    A. Arrowhead Pharmaceuticals, Inc. has been rated by research analysts at Goldman Sachs, RBC Capital, Piper Sandler, H.C. Wainwright, Jefferies, Morgan Stanley in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.